MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus

被引:38
作者
Hezova, Renata [1 ,3 ]
Kovarikova, Alena [1 ]
Srovnal, Josef [2 ]
Zemanova, Milada [4 ]
Harustiak, Tomas [5 ]
Ehrmann, Jiri [2 ]
Hajduch, Marian [2 ]
Sachlova, Milana [3 ]
Svoboda, Marek [3 ]
Slaby, Ondrej [1 ,3 ]
机构
[1] Masaryk Univ, Cent European Inst Technol CEITEC, Kamenice 5, Brno 62500, Czech Republic
[2] Palacky Univ, Fac Med, CR-77147 Olomouc, Czech Republic
[3] Masaryk Mem Canc Inst, Dept Comprehens Canc Care, Brno, Czech Republic
[4] Gen Univ Hosp Prague, Dept Oncol, Prague, Czech Republic
[5] Univ Hosp Motol, Dept Surg, Prague, Czech Republic
关键词
Esophageal adenocarcinoma; Esophageal squamous cell carcinoma; miR-205; Tumor suppressor; Oncogene; MICRORNA EXPRESSION; BREAST-CANCER; NODE METASTASIS; PROLIFERATION; PROMOTES; PROGRESSION; PROFILES; MELANOMA; PROSTATE; INVASION;
D O I
10.1007/s13277-015-4656-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Esophageal cancer is a malignant disease with poor prognosis, increasing incidence, and ineffective treatment options. MicroRNAs are post-transcriptional regulators of gene expression involved in many biological processes including carcinogenesis. We determined miR-205 expression levels in tumor/non-tumor tissues of 45 esophageal cancer patients using qPCR and found that decreased level of miR-205 in tumor tissue correlates with poor overall survival in esophageal adenocarcinoma patients. Further, we observed significantly higher levels of miR-205 in tumor tissue of esophageal squamous cell carcinoma. Ectopic overexpression of miR-205 in adenocarcinoma cell line SK-GT-4 led to decreased cell proliferation, cell cycle arrest in G1, and decreased migration ability. Conversely, in squamous cell line KYSE-150, same effects like inhibition of proliferation, migration, and colony-forming potential and cell cycle arrest in G2 were observed after silencing of miR-205. We performed global gene expression profiling and revealed that suppressive functioning of miR-205 in adenocarcinoma could be realized through regulation of epithelial-mesenchymal transition (EMT), whereas oncogenic in squamous cell carcinoma by regulation of metalloproteinase 10. Our results suggest that miR-205 could serve as biomarker in esophageal cancer and acts as a tumor suppressor in esophageal adenocarcinoma and oncogene in esophageal squamous cell carcinoma.
引用
收藏
页码:8007 / 8018
页数:12
相关论文
共 49 条
[21]   Global Cancer Statistics [J].
Jemal, Ahmedin ;
Bray, Freddie ;
Center, Melissa M. ;
Ferlay, Jacques ;
Ward, Elizabeth ;
Forman, David .
CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (02) :69-90
[22]   Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer [J].
Kelsen, David P. ;
Winter, Katryn A. ;
Gunderson, Leonard L. ;
Mortimer, Joanne ;
Estes, Norman C. ;
Haller, Daniel G. ;
Ajani, Jaffer A. ;
Kocha, Walter ;
Minsky, Bruce D. ;
Roth, Jack A. ;
Willett, Christopher G. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3719-3725
[23]   Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC [J].
Kimura, Sotai ;
Naganuma, Seiji ;
Susuki, Dai ;
Hirono, Yasuo ;
Yamaguchi, Akio ;
Fujieda, Shigeharu ;
Sano, Kazuo ;
Itoh, Hiroshi .
ONCOLOGY REPORTS, 2010, 23 (06) :1625-1633
[24]   miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN [J].
Lei, Lin ;
Huang, Yaping ;
Gong, Wenrong .
ONCOLOGY REPORTS, 2013, 30 (06) :2897-2902
[25]   ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression [J].
Li, Kai ;
Yao, Ling ;
Chen, Li ;
Cao, Zhi-Gang ;
Yu, San-Jian ;
Kuang, Xia-Ying ;
Hu, Xin ;
Shao, Zhi-Ming .
ONCOTARGETS AND THERAPY, 2014, 7 :1083-1094
[26]   MicroRNA expression profiles classify human cancers [J].
Lu, J ;
Getz, G ;
Miska, EA ;
Alvarez-Saavedra, E ;
Lamb, J ;
Peck, D ;
Sweet-Cordero, A ;
Ebet, BL ;
Mak, RH ;
Ferrando, AA ;
Downing, JR ;
Jacks, T ;
Horvitz, HR ;
Golub, TR .
NATURE, 2005, 435 (7043) :834-838
[27]   MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer [J].
Majid, Shahana ;
Saini, Sharanjot ;
Dar, Altaf A. ;
Hirata, Hiroshi ;
Shahryari, Varahram ;
Tanaka, Yuichiro ;
Yamamura, Soichiro ;
Ueno, Koji ;
Zaman, Mohd Saif ;
Singh, Kamaldeep ;
Chang, Inik ;
Deng, Guoren ;
Dahiya, Rajvir .
CANCER RESEARCH, 2011, 71 (07) :2611-2621
[28]   Prognostic Significance of Metastasis-Related MicroRNAs in Early Breast Cancer Patients with a Long Follow-up [J].
Markou, Athina ;
Yousef, George M. ;
Stathopoulos, Efstathios ;
Georgoulias, Vassilis ;
Lianidou, Evi .
CLINICAL CHEMISTRY, 2014, 60 (01) :197-205
[29]   MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells [J].
Matsushima, Kayoko ;
Isomoto, Hajime ;
Yamaguchi, Naoyuki ;
Inoue, Naoki ;
Machida, Haruhisa ;
Nakayama, Toshiyuki ;
Hayashi, Tomayoshi ;
Kunizaki, Masaki ;
Hidaka, Shigekazu ;
Nagayasu, Takeshi ;
Nakashima, Masahiro ;
Ujifuku, Kenta ;
Mitsutake, Norisato ;
Ohtsuru, Akira ;
Yamashita, Shunichi ;
Korpal, Manav ;
Kang, Yibin ;
Gregory, Philip A. ;
Goodall, Gregory J. ;
Kohno, Shigeru ;
Nakao, Kazuhiko .
JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
[30]   MicroRNA profiling of a CD133+ spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line [J].
Nam, Eun Ji ;
Lee, Maria ;
Yim, Ga Won ;
Kim, Jae Hoon ;
Kim, Sunghoon ;
Kim, Sang Wun ;
Kim, Young Tae .
BMC MEDICAL GENOMICS, 2012, 5